We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Heart Kept Alive Outside Body for 12 Hours

By HospiMedica staff writers
Posted on 17 Oct 2001
In an experiment that may eventually expand the pool of available organs for transplantation, researchers at the University of Pittsburgh Medical Center (UPMC, PA, USA) were able to keep a human heart alive outside the body for nearly 12 hours. More...
They used a new experimental organ preservation and transportation system.

Currently, organs are packed in coolers filled with ice and special solutions and can be preserved safely for limited periods of time, called cold ischemic time. The cold ischemic time for the heart, once removed from a donor and with no blood supply, is about six hours. The new system, called the Portable Organ Preservation System (POPS), was developed by TransMedics, Inc. (Woburn, MA, USA). The POPS maintained the human heart in its normal physiologic state, with continuous blood flow, for about 12 hours before researchers elected to disconnect the organ for additional testing. The technique might also reduce or eliminate the cell destruction to the donor organ that sometimes results when oxygenated blood is reintroduced into the organ during transplant surgery.

The POPS weighs about 70 pounds and is shaped like a box that can fit in an ambulance or private jet. The system includes a four-hour battery, an electro-perfusion device, bio-compatible organ-specific components and proprietary chemical solutions that bathe the organ. The researchers say that perfusion with POPS may result in improved organ function by ‘resuscitating' previously unusable organs. POPS may also allow the use of hearts and lungs from non-heart-beating donors.

"Current technology provides only a small window of opportunity to transport and transplant an organ, thereby greatly limiting the availability of organs to those in need,” said Robert Kormos, M.D., professor of surgery and director of thoracic transplantation at UPMC. "A longer preservation time would allow us to share organs across greater distances, and more patients would benefit from life-saving transplants.”




Related Links:
Univ. of Pittsburgh Medical Center

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.